Purification Solutions For The Cell And Gene Therapy Sector
Source: Astrea Bioseparations
The cell and gene therapy sector is growing fast, but is current technology able to keep up? Marc Hummersone, Senior R&D Director at Astrea Bioseparations, discusses the limitations of current technologies, how they're tackling them by creating purpose built solutions, and how collaborations with companies such as VectorBuilder are vital to provide effective testing of their purification systems.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Astrea Bioseparations
This website uses cookies to ensure you get the best experience on our website. Learn more